EMERGENT BIOSOLUTIONS INC. Long-term Purchase Commitment, Amount
EMERGENT BIOSOLUTIONS INC. (EBS) reported Long-term Purchase Commitment, Amount of $88.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LongTermPurchaseCommitmentAmount · last filed 2026-02-27
- EMERGENT BIOSOLUTIONS INC. long-term purchase commitment, amount for fiscal 2025 was $88.60M, a 7.80% decline from fiscal 2024.
- EMERGENT BIOSOLUTIONS INC. long-term purchase commitment, amount for fiscal 2024 was $96.10M, a 10.85% decline from fiscal 2023.
- EMERGENT BIOSOLUTIONS INC. long-term purchase commitment, amount for fiscal 2023 was $107.80M, a 45.99% decline from fiscal 2022.
- EMERGENT BIOSOLUTIONS INC. long-term purchase commitment, amount for fiscal 2022 was $199.60M, a 80.31% increase from fiscal 2021.
| Period end | Long-term Purchase Commitment, Amount 12 month |
|---|---|
| 2025-12-31 | $88.60M 10-K · filed 2026-02-27 |
| 2024-12-31 | $96.10M 10-K · filed 2026-02-27 |
| 2023-12-31 | $107.80M 10-K · filed 2026-02-27 |
| 2022-12-31 | $199.60M 10-K · filed 2025-03-04 |
| 2021-12-31 | $110.70M 10-K · filed 2024-03-08 |
| 2020-12-31 | $108.00M 10-K/A · filed 2023-12-11 |
| 2019-12-31 | $51.30M 10-K · filed 2022-02-25 |
| 2018-12-31 | $12.10M 10-K · filed 2021-02-19 |
| 2017-12-31 | $3.00M 10-K · filed 2020-02-25 |
| 2016-12-31 | $4.50M 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |